Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Numinus Wellness Inc
T.NUMI
Alternate Symbol(s):
NUMIF
Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and...
provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSX:NUMI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(244)
•••
trader53
X
View Profile
View Bullboard History
Post by
trader53
on Apr 27, 2021 4:32pm
Far to much hype on MMED and NUMI went on the joyride..
The first dollar of smoke of MMED evaporated today and I fully expect that another dollar will evaporate by weeks end. If I am right and MMED loses another dollar I am afraid that Numi will be back in
...more
(32)
•••
cressco
X
View Profile
View Bullboard History
Post by
cressco
on Apr 27, 2021 2:39pm
Unfortunately
This is what happens when you gain value on someone else's hype. Numi gained maybe 1/3rd of Mmed's % gains, and is down equal % on a brutal day. Mmed still sitting at 100% gains from recent
...more
(13)
•••
LatAmBull
X
View Profile
View Bullboard History
Comment by
LatAmBull
on Apr 26, 2021 2:36pm
RE:Resistance @ 1.25
Highest volumes on the TSXV today; ~11M shares by 2:20 pm. At this rate will power through that resistance in no time :D!
(32)
•••
cressco
X
View Profile
View Bullboard History
Post by
cressco
on Apr 26, 2021 2:15pm
Resistance @ 1.25
50 dma is 1.24 and pp took place at these levels.
(32)
•••
cressco
X
View Profile
View Bullboard History
Comment by
cressco
on Apr 26, 2021 11:18am
RE:RE:The volume is
I agree. That gap up to high 1.3s could get filled today.
(13)
•••
LatAmBull
X
View Profile
View Bullboard History
Comment by
LatAmBull
on Apr 26, 2021 11:01am
RE:The volume is
SP about to fly, especially once we break through $1.25. LFG!! GLTA!!
(32)
•••
cressco
X
View Profile
View Bullboard History
Post by
cressco
on Apr 26, 2021 10:58am
The volume is
Bananas..
(32)
•••
cressco
X
View Profile
View Bullboard History
Comment by
cressco
on Apr 26, 2021 10:58am
RE:More on the PHASE 1 Clinical Trail details
Nice read. Ty.
(13)
•••
LatAmBull
X
View Profile
View Bullboard History
Post by
LatAmBull
on Apr 26, 2021 10:34am
A Massive Catalyst - Wall Street gets psychedelic
MindMed tomorrow is set to become the second psychedelic drug developer to go public in the U.S., with a third right around the corner (ATAI Life Sciences). This will surely raise the profile of
...more
(63)
•••
rideitout
X
View Profile
View Bullboard History
Post by
rideitout
on Apr 26, 2021 9:09am
More on the PHASE 1 Clinical Trail details
Numinus Executives Dish on Details of Its Upcoming Phase 1 Clinical Trial Using Natural Psilocybin - The Dales Report
(63)
•••
rideitout
X
View Profile
View Bullboard History
Post by
rideitout
on Apr 26, 2021 8:44am
another positive move
Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants (ceo.ca)
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 26, 2021 7:11am
Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Ex
Numinus Wellness is undertaking further studies of its psilocybin products. The company this morning announced a partnership with KGK Science, whereby it will begin studying a psilocybin extract
...more
(2)
•••
Mycelium
X
View Profile
View Bullboard History
Comment by
Mycelium
on Apr 25, 2021 10:58pm
RE:Check Out SHRM Up And Trading
Great news for SHRM!!! How frustrating it has been for the company and its investors. How would you rank the company? I know they have clinics, but are they also into R&D?
(32)
•••
cressco
X
View Profile
View Bullboard History
Comment by
cressco
on Apr 24, 2021 8:25pm
RE:RE:RE:Ok.
Multi day runners looks doable. This could re test 1.9s bfr a nice pullback if this insane volume (8 million +) holds up. Would be awesome to have a nice news release on clinic acquisitions and some
...more
(156)
•••
newcoin
X
View Profile
View Bullboard History
Post by
newcoin
on Apr 24, 2021 5:46pm
Check Out SHRM Up And Trading
https://champignonbrands.com/news/champignon-brands-announces-revocation-of-cease-trade-orders/
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >